Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The CD44v6-negative phenotype in high-grade uterine carcinomas correlates with serous histologic subtype.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 Feb 1998

Soslow R A, Shen P U, Isacson C, Chung M H

Abstract excerpt

Uterine serous carcinomas (USCs) and poorly differentiated (International Federation of Gynecology and Obstetrics Grade 3) endometrioid adenocarcinomas (ECs) are two histologic subtypes of high-grade uterine carcinoma that differ in clinical presentation, patterns of dissemination, and biologic aggressiveness. To investigate the mechanisms responsible for this heterogeneity, we studied CD44 and CD44v6 expression...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Biomarkers, Tumor

Share to Hyaluronan Receptors

Share to Neoplasm Proteins

Share to Neoplasm Staging

Share to Phenotype

Share to Uterine Neoplasms

Source

Identifiers

PMID: 9504691

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The CD44v6-negative phenotype in high-grade uterine carcinomas correlates with serous histologic subtype.PMID 9504691Read ↗

Expression of CD44 variant 6 and its prognostic value in benign and malignant endometrial tissue.Semantic proximity Read ↗

[CD44 splice variants as prognostic factors in invasive cervix carcinoma].Semantic proximity Read ↗

CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer PrognosisSemantic proximity Read ↗

Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profilingSemantic proximity Read ↗

Expression of CD44 alternative splicing variants in primary and lymph node metastatic lesions of gynecological cancer.Semantic proximity Read ↗

Menstrual cycle dependent expression of CD44 in normal human endometrium.Semantic proximity Read ↗

Aberrant Claudin-6–Adhesion Signaling Promotes Endometrial Cancer Progression via Estrogen Receptor αSemantic proximity Read ↗

Aberrant claudin-6–adhesion signal promotes endometrial cancer progression via estrogen receptor αSemantic proximity Read ↗

Immunohistochemical comparison of uterine papillary serous and papillary endometrioid carcinoma: clues to pathogenesis.Semantic proximity Read ↗

Differential expression of CD44 variant isoforms by cell lines and tissue specimens of transitional cell carcinomas.Semantic proximity Read ↗

Lack of CD44 variant 6 expression in rectal cancer invasive front associates with early recurrence.Semantic proximity Read ↗

Prognostic value of CD44 splice variants in human stage III cervical cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.